The impact of his work is visible. His work in reducing signal processing latency to under 50ms leads to continuous biosignal processing with minimal lag, which is critical for emergency medical ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s ...